We have located links that may give you full text access.
Variations in the incidence and burden of illnesses and injuries among non-retiree service members in the earliest, middle, and last 6 months of their careers, active component, U.S. Armed Forces, 2000-2015.
MSMR 2018 June
This report uses routinely collected data in the Defense Medical Surveillance System (DMSS) to characterize the incidence and burden of medical conditions throughout the careers of service members separating from the active component of the U.S. Armed Forces between 1 October 2014 and 30 September 2015. Three surveillance periods between 30 September 2000 and 30 September 2015 were defined by each individual's time in service: early (first 6 months), middle (middle 6 months), and late (last 6 months). Overall, separating service members were most often aged 25-34 years (59.4%), male (84.0%), non-Hispanic white (64.0%), junior enlisted (52.4%), in the Marine Corps (33.1%), serving in a repair/engineering occupation (33.0%), and had never deployed (52.5%). The top five burden of disease categories across surveillance periods by sex were remarkably similar, including mental health disorders, which exhibited similar upward trends across the three surveillance periods (males: 1.3%, 17.0%, and 35.6%; females: 1.8%, 15.1%, and 32.4%, respectively). The most common diagnoses exhibiting upward, downward, or bimodal trends by incidence rate differences were mental health disorders, respiratory infections/diseases, and musculoskeletal diseases, respectively.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app